Genetic testing improves blood thinner dosing

Researchers found that genetics-based dosing for the blood thinner warfarin reduces the risk of major side effects in older patients starting the medication.
Source: NIH Research Matters from the National Institutes of Health (NIH) - Category: Consumer Health News Source Type: news